Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00010231
What this trial is testing

Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
University of Pittsburgh 22
Not applicableLooking for participantsNCT06325046
What this trial is testing

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Mayo Clinic 164
Testing effectiveness (Phase 2)Study completedNCT00752739
What this trial is testing

Selenium in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
University of Arizona 220
Testing effectiveness (Phase 2)Study completedNCT01026623
What this trial is testing

Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 16
Early research (Phase 1)WithdrawnNCT00005827
What this trial is testing

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00689065
What this trial is testing

Safety Study of CALAA-01 to Treat Solid Tumor Cancers

Who this might be right for
CancerSolid Tumor
Calando Pharmaceuticals 24
Early research (Phase 1)Ended earlyNCT00096304
What this trial is testing

Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Medical University of South Carolina 36
Testing effectiveness (Phase 2)Study completedNCT00450411
What this trial is testing

Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 100
Early research (Phase 1)Study completedNCT02532114
What this trial is testing

Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
University of Washington 5
Early research (Phase 1)UnknownNCT00003633
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Herbert Irving Comprehensive Cancer Center 12
Not applicableWithdrawnNCT04399824
What this trial is testing

Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage II Prostate Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00003607
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
UNICANCER 450
Testing effectiveness (Phase 2)Study completedNCT00252941
What this trial is testing

Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma

Who this might be right for
Prostate CancerPost-Brachytherapy Bladder Outlet Obstruction
The Cleveland Clinic 20
Testing effectiveness (Phase 2)Ended earlyNCT00503984
What this trial is testing

A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients

Who this might be right for
Prostate CancerPain
University of Miami 22
Early research (Phase 1)Study completedNCT00305669
What this trial is testing

GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 24
Not applicableLooking for participantsNCT03880422
What this trial is testing

Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer

Who this might be right for
Cancer SurvivorObesityOverweight+17 more
Roswell Park Cancer Institute 50
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00561262
What this trial is testing

High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
University College London Hospitals 60
Not applicableStudy completedNCT00402285
What this trial is testing

Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 84
Testing effectiveness (Phase 2)Ended earlyNCT00526591
What this trial is testing

Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Jorge A. Garcia, MD 17
Next Page